Table 4.

Patient outcome and survival

	All patients (n = 282)	Patients without visceral metastasis (n = 220)		Patients with visceral metastasis (n = 62)
		Curative treatment (n = 151)	BSC (n = 69)	Palliative treatment (n = 30)	BSC (n = 32)
Overall survival (month, SD)	9.7 ± 1.0	17.8 ± 1.5	5.5 ± 2.0 *	6.7 ± 2.1	1.8 ± 0.4 **
Specific survival (month, SD)	11.5 ± 0.7	23.2 ± 5.3	6.1 ± 2.5 *	6.7 ± 2.1	1.8 ± 0.4 **
Deaths	206 (73.0%)	113 (74.8%)	42 (60.9%)	24 (80.0%)	27 (84.4%)
Causes of death
cancer	181 (87.9%)	91 (80.5%)	40 (95.2%)	24 (100%)	26 (96.3%)
treatment	5 (2.4%)	3 (2.6%)	1 (2.4%)	0	1 (3.7%)
other	20 (9.7%)	19 (16.8%)	1 (2.4%)	0	0

n: number of patients, SD: standard deviation, BSC: best supportive care, *: p < 0.05 curative treatment vs BSC, **: p < 0.05 palliative treatment vs BSC